Literature DB >> 31668688

Metabolomics of Aerobic Exercise in Chronic Stroke Survivors: A Pilot Study.

Monica C Serra1, Carolyn J Accardi2, Chunyu Ma2, Younja Park3, ViLinh Tran2, Dean P Jones2, Charlene E Hafer-Macko4, Alice S Ryan4.   

Abstract

BACKGROUND: Understanding the metabolic response to exercise may aid in optimizing stroke management. Therefore, the purpose of this pilot study was to evaluate plasma metabolomic profiles in chronic stroke survivors following aerobic exercise training.
METHODS: Participants (age: 62 ± 1 years, body mass index: 31 ± 1 kg/m2, mean ± standard error of the mean) were randomized to 6 months of treadmill exercise (N = 17) or whole-body stretching (N = 8) with preintervention and postintervention measurement of aerobic capacity (VO2peak). Linear models for microarray data expression analysis was performed to determine metabolic changes over time, and Mummichog was used for pathway enrichment analysis following analysis of plasma samples by high-performance liquid chromatography coupled to ultrahigh resolution mass spectrometry.
RESULTS: VO2peak change was greater following exercise than stretching (18.9% versus -.2%; P < .01). Pathway enrichment analysis of differentially expressed metabolites results showed significant enrichment in 4 pathways following treadmill exercise, 3 of which (heparan-, chondroitin-, keratan-sulfate degradation) involved connective tissue metabolism and the fourth involve lipid signaling (linoleate metabolism). More pathways were altered in pre and post comparisons of stretching, including branched-chain amino acid, tryptophan, tyrosine, and urea cycle, which could indicate loss of lean body mass.
CONCLUSIONS: These preliminary data show different metabolic changes due to treadmill training and stretching in chronic stroke survivors and suggest that in addition to improved aerobic capacity, weight-bearing activity, like walking, could protect against loss of lean body mass. Future studies are needed to examine the relationship between changes in metabolomic profiles to reductions in cardiometabolic risk after treadmill rehabilitation. Published by Elsevier Inc.

Entities:  

Keywords:  Stroke; aerobic fitness; exercise; metabolomics

Mesh:

Substances:

Year:  2019        PMID: 31668688      PMCID: PMC6996235          DOI: 10.1016/j.jstrokecerebrovasdis.2019.104453

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  46 in total

1.  Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research.

Authors:  Young-Mi Go; Douglas I Walker; Yongliang Liang; Karan Uppal; Quinlyn A Soltow; ViLinh Tran; Frederick Strobel; Arshed A Quyyumi; Thomas R Ziegler; Kurt D Pennell; Gary W Miller; Dean P Jones
Journal:  Toxicol Sci       Date:  2015-09-09       Impact factor: 4.849

Review 2.  Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology.

Authors:  Vincenza Frisardi; Francesco Panza; Davide Seripa; Tahira Farooqui; Akhlaq A Farooqui
Journal:  Prog Lipid Res       Date:  2011-06-15       Impact factor: 16.195

3.  Low-velocity graded treadmill stress testing in hemiparetic stroke patients.

Authors:  R F Macko; L I Katzel; A Yataco; L D Tretter; C A DeSouza; D R Dengel; G V Smith; K H Silver
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

4.  Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women.

Authors:  S N Blair; J B Kampert; H W Kohl; C E Barlow; C A Macera; R S Paffenbarger; L W Gibbons
Journal:  JAMA       Date:  1996-07-17       Impact factor: 56.272

5.  Metabolomics investigation of exercise-modulated changes in metabolism in rat liver after exhaustive and endurance exercises.

Authors:  Chi-Chang Huang; Wan-Teng Lin; Feng-Lin Hsu; Pi-Wen Tsai; Chia-Chung Hou
Journal:  Eur J Appl Physiol       Date:  2009-10-29       Impact factor: 3.078

6.  Higher Treadmill Training Intensity to Address Functional Aerobic Impairment after Stroke.

Authors:  Frederick M Ivey; Alyssa D Stookey; Charlene E Hafer-Macko; Alice S Ryan; Richard F Macko
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-08-21       Impact factor: 2.136

Review 7.  From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis.

Authors:  Lilian Aly; Bernhard Hemmer; Thomas Korn
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  A pilot study comparing the metabolic profiles of elite-level athletes from different sporting disciplines.

Authors:  Fatima Al-Khelaifi; Ilhame Diboun; Francesco Donati; Francesco Botrè; Mohammed Alsayrafi; Costas Georgakopoulos; Karsten Suhre; Noha A Yousri; Mohamed A Elrayess
Journal:  Sports Med Open       Date:  2018-01-05

9.  Predicting network activity from high throughput metabolomics.

Authors:  Shuzhao Li; Youngja Park; Sai Duraisingham; Frederick H Strobel; Nooruddin Khan; Quinlyn A Soltow; Dean P Jones; Bali Pulendran
Journal:  PLoS Comput Biol       Date:  2013-07-04       Impact factor: 4.475

10.  Effect of exercise intervention on changes in free Fatty Acid levels and metabolic risk factors in stroke patients.

Authors:  Dae-Young Kim; Sun-Young Jung; Byoung-Do Seo
Journal:  J Phys Ther Sci       Date:  2014-02-28
View more
  2 in total

1.  Metabolomics Analysis Reveals Alterations in Cochlear Metabolic Profiling in Mice with Noise-Induced Hearing Loss.

Authors:  Long Miao; Juan Zhang; Lihong Yin; Yuepu Pu
Journal:  Biomed Res Int       Date:  2022-05-06       Impact factor: 3.246

2.  Associations Between Time After Stroke and Exercise Training Outcomes: A Meta-Regression Analysis.

Authors:  Susan Marzolini; Che-Yuan Wu; Rowaida Hussein; Lisa Y Xiong; Suban Kangatharan; Ardit Peni; Christopher R Cooper; Kylie S K Lau; Ghislaine Nzodjou Makhdoom; Maureen Pakosh; Stephanie A Zaban; Michelle M Nguyen; Mohammad Amin Banihashemi; Walter Swardfager
Journal:  J Am Heart Assoc       Date:  2021-12-16       Impact factor: 6.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.